42nd Annual Meeting of the American-Society-of-Hematology Conference

Scholarly Activity

related documents

Treatment of the Chronic Phase of Chronic Myeloid Leukemia with an Intermittent Schedule of Recombinant Interferon Alfa-2b and Cytarabine: Results from CALGB Study 9013 Conferences